Artiva Biotherapeutics, Inc. ARTV Payments Of Stock Issuance Costs
Payments Of Stock Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.
The official record: Artiva Biotherapeutics, Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s payments of stock issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s payments of stock issuance costs?
- Artiva Biotherapeutics, Inc. (ARTV) reported payments of stock issuance costs of -$0 in Q4 2025.
- How has Artiva Biotherapeutics, Inc.'s payments of stock issuance costs changed year-over-year?
- Artiva Biotherapeutics, Inc.'s payments of stock issuance costs decreased by 100.0% year-over-year, from $20K to -$0.
- What does payments of stock issuance costs mean?
- Includes direct costs incurred in connection with the issuance of equity securities, such as underwriting fees, legal fees, and accounting expenses. These costs are treated as a reduction of the proceeds from equity financing activities.